Walleye Trading
VKTX icon

Walleye Trading’s Viking Therapeutics VKTX Stock Holding History

Walleye Trading’s Portfolio VKTX Stock Details VKTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$11.8M Sell
363,700
-26,100
-7% -$839K 0.02% 709
2025
Q4 		$13.7M Sell
389,800
-8,800
-2% -$312K 0.02% 783
2025
Q3 		$10.5M Buy
398,600
+68,400
+21% +$2.04M 0.02% 873
2025
Q2 		$8.75M Buy
330,200
+304,200
+1,170% +$8.01M 0.02% 880
2025
Q1 		$628K Buy
26,000
+16,200
+165% +$512K ﹤0.01% 2369
2024
Q4 		$394K Sell
9,800
-33,700
-77% -$1.92M ﹤0.01% 2795
2024
Q3 		$2.75M Buy
43,500
+41,100
+1,713% +$2.41M 0.01% 1478
2024
Q2 		$127K Sell
2,400
-6,400
-73% -$420K ﹤0.01% 3287
2024
Q1 		$722K Sell
8,800
-27,700
-76% -$1.23M ﹤0.01% 2501
2023
Q4 		$679K Buy
36,500
+19,000
+109% +$248K ﹤0.01% 2801
2023
Q3 		$194K Buy
17,500
+10,100
+136% +$144K ﹤0.01% 3624
2023
Q2 		$120K Buy
7,400
+2,800
+61% +$58.7K ﹤0.01% 3674
2023
Q1 		$76.6K Sell
4,600
-24,900
-84% -$257K ﹤0.01% 3948
2022
Q4 		$277K Buy
+29,500
New +$132K ﹤0.01% 3313
2020
Q4 		– Sell
-20,000
Closed -$116K – 4963
2020
Q3 		$116K Sell
20,000
-4,000
-17% -$27.5K ﹤0.01% 3327
2020
Q2 		$173K Buy
24,000
+13,300
+124% +$88.3K ﹤0.01% 3178
2020
Q1 		$50K Sell
10,700
-165,400
-94% -$1.02M ﹤0.01% 3415
2019
Q4 		$1.41M Buy
+176,100
New +$1.28M 0.01% 1500
2019
Q3 		– Sell
-87,900
Closed -$730K – 4470
2019
Q2 		$730K Sell
87,900
-104,900
-54% -$896K 0.01% 1871
2019
Q1 		$1.92M Buy
192,800
+99,000
+106% +$829K 0.01% 1108
2018
Q4 		$718K Buy
93,800
+91,600
+4,164% +$1.1M 0.01% 2095
2018
Q3 		$38K Buy
+2,200
New +$26.2K ﹤0.01% 4661

Other funds holding VKTX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $324B AUM 22.36% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

Walleye Trading's VKTX Position: Q1 2026 in Review

Walleye Trading reduced its Viking Therapeutics (VKTX) stake by 95% in Q1 2026, selling an estimated $6.49M and leaving 10,007 shares worth $326K. The position accounts for ﹤0.01% of the portfolio, ranked #2837.

Walleye Trading first reported a position in VKTX in Q1 2018 and has held it in 18 quarters since. The position peaked at $7.45M in Q4 2025. 410 funds tracked by Wall St. Rank hold VKTX as of Q1 2026.

  • Walleye Trading held 10,007 shares of Viking Therapeutics worth $326K as of Q1 2026.
  • Walleye Trading sold 201,897 Viking Therapeutics shares in Q1 2026, an estimated $6.49M.
  • Viking Therapeutics made up ﹤0.01% of Walleye Trading's portfolio in Q1 2026, its #2837 holding.
  • Walleye Trading first reported a position in Viking Therapeutics in Q1 2018 and has held it in 18 quarters since.
  • Walleye Trading's Viking Therapeutics position peaked at $7.45M in Q4 2025.
  • 410 funds tracked by Wall St. Rank held Viking Therapeutics as of Q1 2026.

Based on Walleye Trading's 13F filing for Q1 2026, filed 11 May 2026.